Biotech
SAN FRANCISCO, CA and TOKYO: Six Abstracts Presented Include Data from Phase II Study Investigating XTANDI(R) (enzalutamide) Capsules in Hormone-Naive Prostate Cancer
...
DALLAS, TX and WARWICK, RI: Enables a Wider Variety of Drugs and Biologically-Based Entities to Be Effectively Used in Implantable Fiber-Based Medical Devices
...
WINNIPEG, MANITOBA: PreVu Test May One Day Help Monitor Patients on Cholesterol Lowering Medication
...
LEUVEN, BELGIUM: TiGenix to Present at 15th Annual BIO CEO & Investor Conference
...
SAN DIEGO, CA: New Approach for Deep Tissue Imaging of Tumors and Treating Cancer With Thermotherapy Published in PNAS
...
SAN DIEGO, CA: Paul Cleveland Joins as EVP of Corporate Strategy and Chief Financial Officer
...
SAN FRANCISCO, CA: High-Dose Pexa-Vec Associated With Statistically Significant Improvement in Median Survival Versus Low-Dose Pexa-Vec (14.1 Months vs. 6.7 Months)
...
SOUTH SAN FRANCISCO, CA: Latest Developments Enable Advanced Tools for Drug Rescue and Potential Cell Therapies Based on Human Definitive Hematopoietic Precursor Cells
...
CAMBRIDGE, MA: Evening Workshop on Using Advanced Mass Spectrometry and Biophysical Methods Follows MassBio's CRO/CMO Symposium on February 25th in Boston
...
